BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin H, Teng H, Wu W, Li Y, Lv G, Huang X, Yan W, Lin Z. Pharmacokinetic and metabolomic analyses of Mangiferin calcium salt in rat models of type 2 diabetes and non-alcoholic fatty liver disease. BMC Pharmacol Toxicol 2020;21:59. [PMID: 32762728 DOI: 10.1186/s40360-020-00438-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang M, Liang Y, Chen K, Wang M, Long X, Liu H, Sun Y, He B. The management of diabetes mellitus by mangiferin: advances and prospects. Nanoscale 2022;14:2119-35. [PMID: 35088781 DOI: 10.1039/d1nr06690k] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
2 Xu L, Ling J, Su C, Su YW, Xu Y, Jiang Z. Emerging Roles on Immunological Effect of Indoleamine 2,3-Dioxygenase in Liver Injuries. Front Med (Lausanne) 2021;8:756435. [PMID: 34869457 DOI: 10.3389/fmed.2021.756435] [Reference Citation Analysis]
3 Mei S, Perumal M, Battino M, Kitts DD, Xiao J, Ma H, Chen X. Mangiferin: a review of dietary sources, absorption, metabolism, bioavailability, and safety. Crit Rev Food Sci Nutr 2021;:1-19. [PMID: 34606395 DOI: 10.1080/10408398.2021.1983767] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
4 Chen SS, Huang Y, Guo YM, Li SS, Shi Z, Niu M, Zou ZS, Xiao XH, Wang JB. Serum Metabolomic Analysis of Chronic Drug-Induced Liver Injury With or Without Cirrhosis. Front Med (Lausanne) 2021;8:640799. [PMID: 33855035 DOI: 10.3389/fmed.2021.640799] [Cited by in F6Publishing: 3] [Reference Citation Analysis]